Ovarian Cancer-Cell Pericellular Hyaluronan Deposition Negatively Impacts Prognosis of Ovarian Cancer Patients

Background: Hyaluronan (HA), a component of the extracellular matrix, is frequently increased under pathological conditions including cancer. Not only stroma cells but also cancer cells themselves synthesize HA, and the interaction of HA with its cognate receptors promotes malignant progression and...

Full description

Bibliographic Details
Main Authors: Leticia Oliveira-Ferrer, Barbara Schmalfeldt, Johannes Dietl, Catharina Bartmann, Udo Schumacher, Christine Stürken
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/10/11/2944
_version_ 1797465876565327872
author Leticia Oliveira-Ferrer
Barbara Schmalfeldt
Johannes Dietl
Catharina Bartmann
Udo Schumacher
Christine Stürken
author_facet Leticia Oliveira-Ferrer
Barbara Schmalfeldt
Johannes Dietl
Catharina Bartmann
Udo Schumacher
Christine Stürken
author_sort Leticia Oliveira-Ferrer
collection DOAJ
description Background: Hyaluronan (HA), a component of the extracellular matrix, is frequently increased under pathological conditions including cancer. Not only stroma cells but also cancer cells themselves synthesize HA, and the interaction of HA with its cognate receptors promotes malignant progression and metastasis. Methods: In the present study, HA deposition in tissue sections was analyzed by hyaluronan-binding protein (HABP) ligand histochemistry in 17 borderline tumors and 102 primary and 20 recurrent ovarian cancer samples. The intensity and, particularly, localization of the HA deposition were recorded: for the localization, the pericellular deposition around the ovarian cancer cells was distinguished from the deposition within the stromal compartment. These histochemical data were correlated with clinical and pathological parameters. Additionally, within a reduced subgroup of ovarian cancer samples (<i>n</i> = 70), the RNA levels of several HA-associated genes were correlated with the HA localization and intensity. Results: Both stroma-localized and pericellular tumor-cell-associated HA deposition were observed. Cancer-cell pericellular HA deposition, irrespective of its staining intensity, was significantly associated with malignancy, and in the primary ovarian cancer cohort, it represents an independent unfavorable prognostic marker for overall survival. Furthermore, a significant association between high CD44, HAS2 and HAS3 mRNA levels and a cancer-cell pericellular HA-deposition pattern was noted. In contrast, stromal hyaluronan deposition had no impact on ovarian cancer prognosis. Conclusions: In conclusion, the site of HA deposition is of prognostic value, but the amount deposited is not. The significant association of only peritumoral cancer-cell HA deposition with high CD44 mRNA expression levels suggests a pivotal role of the CD44–HA signaling axis for malignant progression in ovarian cancer.
first_indexed 2024-03-09T18:27:48Z
format Article
id doaj.art-d79d59cb4d5543f78e27ae938c8ff5ca
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-09T18:27:48Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-d79d59cb4d5543f78e27ae938c8ff5ca2023-11-24T07:46:36ZengMDPI AGBiomedicines2227-90592022-11-011011294410.3390/biomedicines10112944Ovarian Cancer-Cell Pericellular Hyaluronan Deposition Negatively Impacts Prognosis of Ovarian Cancer PatientsLeticia Oliveira-Ferrer0Barbara Schmalfeldt1Johannes Dietl2Catharina Bartmann3Udo Schumacher4Christine Stürken5Department of Gynaecology and Gynaecologic Oncology, University Medical Centre Hamburg-Eppendorf, 20246 Hamburg, GermanyDepartment of Gynaecology and Gynaecologic Oncology, University Medical Centre Hamburg-Eppendorf, 20246 Hamburg, GermanyDepartment of Obstetrics and Gynaecology, University of Wuerzburg, 97080 Wuerzburg, GermanyDepartment of Obstetrics and Gynaecology, University of Wuerzburg, 97080 Wuerzburg, GermanyDepartment of Anatomy and Experimental Morphology, University Medical Centre Hamburg-Eppendorf, 20246 Hamburg, GermanyDepartment of Anatomy and Experimental Morphology, University Medical Centre Hamburg-Eppendorf, 20246 Hamburg, GermanyBackground: Hyaluronan (HA), a component of the extracellular matrix, is frequently increased under pathological conditions including cancer. Not only stroma cells but also cancer cells themselves synthesize HA, and the interaction of HA with its cognate receptors promotes malignant progression and metastasis. Methods: In the present study, HA deposition in tissue sections was analyzed by hyaluronan-binding protein (HABP) ligand histochemistry in 17 borderline tumors and 102 primary and 20 recurrent ovarian cancer samples. The intensity and, particularly, localization of the HA deposition were recorded: for the localization, the pericellular deposition around the ovarian cancer cells was distinguished from the deposition within the stromal compartment. These histochemical data were correlated with clinical and pathological parameters. Additionally, within a reduced subgroup of ovarian cancer samples (<i>n</i> = 70), the RNA levels of several HA-associated genes were correlated with the HA localization and intensity. Results: Both stroma-localized and pericellular tumor-cell-associated HA deposition were observed. Cancer-cell pericellular HA deposition, irrespective of its staining intensity, was significantly associated with malignancy, and in the primary ovarian cancer cohort, it represents an independent unfavorable prognostic marker for overall survival. Furthermore, a significant association between high CD44, HAS2 and HAS3 mRNA levels and a cancer-cell pericellular HA-deposition pattern was noted. In contrast, stromal hyaluronan deposition had no impact on ovarian cancer prognosis. Conclusions: In conclusion, the site of HA deposition is of prognostic value, but the amount deposited is not. The significant association of only peritumoral cancer-cell HA deposition with high CD44 mRNA expression levels suggests a pivotal role of the CD44–HA signaling axis for malignant progression in ovarian cancer.https://www.mdpi.com/2227-9059/10/11/2944ovarian cancerstromal hyaluronantumor-associated hyaluronan staining patternhyaluronan-related enzymes
spellingShingle Leticia Oliveira-Ferrer
Barbara Schmalfeldt
Johannes Dietl
Catharina Bartmann
Udo Schumacher
Christine Stürken
Ovarian Cancer-Cell Pericellular Hyaluronan Deposition Negatively Impacts Prognosis of Ovarian Cancer Patients
Biomedicines
ovarian cancer
stromal hyaluronan
tumor-associated hyaluronan staining pattern
hyaluronan-related enzymes
title Ovarian Cancer-Cell Pericellular Hyaluronan Deposition Negatively Impacts Prognosis of Ovarian Cancer Patients
title_full Ovarian Cancer-Cell Pericellular Hyaluronan Deposition Negatively Impacts Prognosis of Ovarian Cancer Patients
title_fullStr Ovarian Cancer-Cell Pericellular Hyaluronan Deposition Negatively Impacts Prognosis of Ovarian Cancer Patients
title_full_unstemmed Ovarian Cancer-Cell Pericellular Hyaluronan Deposition Negatively Impacts Prognosis of Ovarian Cancer Patients
title_short Ovarian Cancer-Cell Pericellular Hyaluronan Deposition Negatively Impacts Prognosis of Ovarian Cancer Patients
title_sort ovarian cancer cell pericellular hyaluronan deposition negatively impacts prognosis of ovarian cancer patients
topic ovarian cancer
stromal hyaluronan
tumor-associated hyaluronan staining pattern
hyaluronan-related enzymes
url https://www.mdpi.com/2227-9059/10/11/2944
work_keys_str_mv AT leticiaoliveiraferrer ovariancancercellpericellularhyaluronandepositionnegativelyimpactsprognosisofovariancancerpatients
AT barbaraschmalfeldt ovariancancercellpericellularhyaluronandepositionnegativelyimpactsprognosisofovariancancerpatients
AT johannesdietl ovariancancercellpericellularhyaluronandepositionnegativelyimpactsprognosisofovariancancerpatients
AT catharinabartmann ovariancancercellpericellularhyaluronandepositionnegativelyimpactsprognosisofovariancancerpatients
AT udoschumacher ovariancancercellpericellularhyaluronandepositionnegativelyimpactsprognosisofovariancancerpatients
AT christinesturken ovariancancercellpericellularhyaluronandepositionnegativelyimpactsprognosisofovariancancerpatients